Publications by authors named "Markus Hell"

Claim this Profile
V
Variability and interpretability of benzylpenicillin inhibition zone edges in Staphylococcus aureus - a multi-center study in Austria.
Felix Lötsch, David N Springer, Brigitte Selitsch, Sonja Lener, Barbara Ströbele, Markus Hell

Eur J Clin Microbiol Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three prolonged outbreaks of metallo-β-lactamase-producing in an Upper Austrian hospital, 2017-2023.
Adriana Cabal, Anna Hörtenhuber, Yarub Salaheddin, Anna Stöger, Burkhard Springer, Markus Hell

Microbiol Spectr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater attention to flexible hospital designs and ventilated clinical facilities are a pre-requisite for coping with the next airborne pandemic.
Hilary Humphreys, Margreet Vos, Elisabeth Presterl, Markus Hell

Clin Microbiol Infect· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Infection prevention and control policies in hospitals and prevalence of highly resistant microorganisms: an international comparative study.
Manon D van Dijk, Anne F Voor In 't Holt, Emine Alp, Markus Hell, Nicola Petrosillo

Antimicrob Resist Infect Control· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection prevention and control policies in hospitals and prevalence of highly resistant microorganisms: an international comparative study.
Manon D van Dijk, Anne F Voor In 't Holt, Emine Alp, Markus Hell, Nicola Petrosillo

Antimicrob Resist Infect Control· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specialist training in medical microbiology across Europe in 2021-an update on the actual training situation based on a survey.
Maeve Doyle, Breida Boyle, Caoimhe Brennan, Jane Holland, Albert Mifsud, Markus Hell

Clin Microbiol Infect· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolate-Based Surveillance of Bordetella pertussis, Austria, 2018-2020.
Adriana Cabal, Daniela Schmid, Markus Hell, Ali Chakeri, Elisabeth Mustafa-Korninger

Emerg Infect Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.
Andreas Stallmach, Veli-Jukka Anttila, Markus Hell, Simon Gwynn, Paloma Merino-Amador

Z Gastroenterol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus reactivation and its clinical impact in patients with solid tumors.
Konstantin Schlick, Michael Grundbichler, Jutta Auberger, Jan Marco Kern, Markus Hell

Infect Agent Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey.
Alexander Indra, Daniela Schmid, Steliana Huhulescu, Erica Simons, Markus Hell

Wien Klin Wochenschr· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct differences in clinical manifestation and viral laboratory parameters between children and adults with influenza A(H1N1)pdm09 infection--a retrospective comparative analysis.
Monika Redlberger-Fritz, Sonja Hirk, Dieter Buchinger, Renate Haberl, Markus Hell

J Med Virol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of Clostridium difficile in asymptomatic hospital staff.
Markus Hell, Kathrin Sickau, Gregor Chmelizek, Jan Marco Kern, Matthias Maass

Am J Infect Control· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of galanin message-associated peptide and neuropeptide Y against various non-albicans Candida strains.
Barbara S Holub, Isabella Rauch, Simone Radner, Wolfgang Sperl, Markus Hell

Int J Antimicrob Agents· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
Simon Auer, Alexandra Wojna, Markus Hell

Antimicrob Agents Chemother· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth and gaseous emissions of pure and mixed small intestinal bacterial cultures: Effects of bile and vancomycin.
Elias Hakalehto, Markus Hell, Christa Bernhofer, Anneli Heitto, Jouni Pesola

Pathophysiology· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006-2007.
Rainer Fretz, Daniela Schmid, Sandra Jelovcan, Rosi Tschertou, Elke Krassnitzer, Markus Hell

Wien Klin Wochenschr· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridium difficile Infection in a Health Care Worker.
Markus Hell, Alexander Indra, Steliana Huhulescu, Franz Allerberger

Clin Infect Dis· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galanin message-associated peptide suppresses growth and the budded-to-hyphal-form transition of Candida albicans.
Isabella Rauch, Linda Lundström, Markus Hell, Wolfgang Sperl, Barbara Kofler

Antimicrob Agents Chemother· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis